ERBB2 and breast cancer: Specifically, CD24 expression in fibroadenomas is higher than in phyllodes tumors, while CD47 is predominantly expressed in drug-resistant HER2+ BC cells (Ahmed et al., 2022; Zhang B. et al., 2024).